ARCHIVES

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

This article is from The Cancer Letter archive.

Vol. 40 No. 01 | January 3, 2014

Download PDF Visit The Full Archive

Related Articles

NIEHS Director Olden Outlines Strategy For Carcinogenicity Testing

September 11, 1992

Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget

December 7, 2012

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000

Brief: President Expected To Propose 4.7% Increase In NIH Budget; Bernard Fisher Wins Award

January 14, 1994

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

July 26, 2013